NYSE:BR - New York Stock Exchange, Inc. - US11133T1034 - Common Stock - Currency: USD
Recursion could help revolutionize the way drugs are developed. Recursion Pharmaceuticals (NASDAQ: RXRX) is not the most famous artificial intelligence (AI) stock on the market, but the biotech (or techbio) company has attracted the attention of some big names. Recursion has partnered with the AI juggernaut Nvidia to build a powerful supercomputer, for example.
/PRNewswire/ -- As active ETF assets have grown over 600% in the past five years to $631 billion in 2024, Broadridge Financial Solutions, Inc. (NYSE: BR), a...
/PRNewswire/ -- LTX, an AI-powered corporate bond trading platform backed by global Fintech leader Broadridge Financial Solutions Inc. (NYSE:BR), today...
Broadridge Financial Solutions leans on strong recurring revenues and rising dividends.
/PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR) announced that its Board of Directors has declared a quarterly cash dividend of $0.88 per share....
/PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR) announced that it will be participating at five upcoming investor events. Three of these events...
Nvidia is scheduled to report quarterly results after the bell on Wednesday, in what could be a major test of the AI trade’s resilience.
On Wednesday, Broadridge Financial Solutions Inc. (NYSE:BR) partnered with Novisto to introduce an advanced sustainability data management and reporting platform for global companies. This partnership will enable organizations to meet evolving investor expectations, simplify third-party questionnaires and rating agency requests, optimize supply chain transparency, and enhance stakeholder engagement on a global scale. The General Manager […]
Partnership delivers end-to-end solution for companies to streamline sustainability data collection amid growing global regulatory demands.
RHI's first-quarter 2025 revenues and earnings decrease year over year.
/PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE: BR) a global Fintech leader, has joined forces with Novisto, a pioneer of enterprise sustainability...
/PRNewswire/ -- Broadridge Financial Solutions Inc. (NYSE:BR) has been awarded a new U.S. patent on its large language model (LLM) orchestration of machine...
/PRNewswire/ -- Growing concerns over operational and cyber resilience were the major theme of the SIFMA Ops 2025 conference, a gathering of top operations and...
Shopify initiated, Comcast downgraded: Wall Street's top analyst calls
/PRNewswire/ -- Global Fintech leader Broadridge Financial Solutions Inc. (NYSE: BR), today announced significant enhancements to OpsGPT® across fails...
BR's third-quarter fiscal 2025 earnings and revenues increased year over year.
Although the revenue and EPS for Broadridge Financial (BR) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
(Reuters) -Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell roughly 10% on investor worries that the move could blunt its sales momentum. Lilly's leading position in weight loss and diabetes treatments has boosted its market value to more than $800 billion, making it the world's most valuable healthcare company. Zepbound's prescription growth has surged ahead of Novo Nordisk's rival GLP-1 weight-loss drug Wegovy in recent months after struggles with supply issues in 2024.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Broadridge Financial (BR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
U.S. stocks fell Monday as investors geared up for a busy day of earnings across sectors, from pizza to semiconductors and sanitation.
TT's first-quarter 2025 performance is anticipated to have been driven by stronger demand for innovative products and improved operational efficiency.
SouthernSun Asset Management, LLC, an investment management firm, released its “SouthernSun SMID Cap Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the strategy returned -8.60% on a gross basis (-8.76% net compared to a -7.50% return for the Russell 2500 Index and -5.83% for […]
/PRNewswire/ -- As retirement planning grows more complex and advisory firms seek scalable, enterprise-wide solutions, OneDigital Financial Services has...